9 completed. 9 Phase 3.
By phase and status
Follow Secondary Hypogonadism: new trials by email Literature Review of Secondary Hypogonadism trials Research Report on Secondary Hypogonadism
Trials (filtered) newest first · largest first
All 9 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% Androxal 12.5 mg/25 mg, Placebo Capsules, AndroGel 1.62% - Secondary Hypogonadism | Phase 3 | Completed | 120 | 2014-01-01 | 2014-10-01 |
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% Androxal 12.5 mg or 25 mg, AndroGel 1.62%, Placebo Capsules - Secondary Hypogonadism | Phase 3 | Completed | 120 | 2014-01-01 | 2014-10-01 |
Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism enclomiphene citrate, Placebo - Secondary Hypogonadism | Phase 3 | Completed | 181 | 2012-11-01 | 2015-05-27 |
An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism Androxal - Secondary Hypogonadism | Phase 3 | Completed | 300 | 2012-11-01 | 2014-04-16 |
Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism Androxal, Placebo - Secondary Hypogonadism | Phase 3 | Completed | 151 | 2012-08-01 | 2015-05-27 |
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism Androxal - Secondary Hypogonadism | Phase 3 | Completed | 499 | 2012-05-01 | 2014-07-24 |
Study to Evaluate the Safety and Efficacy of Androxalâ„¢ Treatment in Men With Secondary Hypogonadism Androxal, AndroGel, Placebo - Secondary Hypogonadism | Phase 3 | Completed | 194 | 2006-03-01 | 2010-02-11 |
Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism Androxal - Secondary Hypogonadism | Phase 3 | Completed | 104 | 2006-03-01 | 2014-06-27 |
Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men Testosterone Undecanoate 750 mg, Testosterone Undecanoate 1000 mg - Hypogonadism, Primary Hypogonadism | Phase 3 | Completed | 531 | 2006-03-01 | 2017-10-05 |
Narrower conditions
Hypogonadism (9)
Broader conditions
Endocrine System Diseases (9) · Gonadal Disorders (9)
Interventions
Enclomiphene (8) · Testosterone (1) · testosterone undecanoate (1)
Sponsors
Repros Therapeutics Inc. (8) · Endo USA Inc., a Keenova Therapeutics Company (1)
Countries
United States (8)
Top investigators
Joseph S Podolski (3) · Andre van As, MD, PhD (2)